Literature DB >> 18306855

The effect of ceramide-containing skin care products on eczema resolution duration.

Zoe Diana Draelos1.   

Abstract

Eczema is a common dermatologic condition that affects children as well as adults and is related to a defective skin barrier, which is most commonly caused by damage to the intercellular lipids from improper selection of skin cleansers and moisturizers. A new concept in skin care is the incorporation of ceramides into therapeutic cleansers and moisturizers. Ceramides are important components of the intercellular lipids that are necessary to link the protein-rich corneocytes into a waterproof barrier that is capable of protecting the underlying skin tissues and regulating body homeostasis. This study evaluated the effect of both a multilamellar vesicular emulsion (MVE) ceramide-containing liquid cleanser and moisturizing cream plus fluocinonide cream 0.05% compared with a bar cleanser plus fluocinonide cream 0.05% in the treatment of mild to moderate eczema. The addition of an MVE ceramide-containing liquid cleanser and moisturizing cream to a high-potency corticosteroid enhanced the treatment outcome of mild to moderate eczema compared with the use of a bar cleanser and high-potency corticosteroid in reducing disease duration, time to disease clearance, and symptoms. Thus, skin care product selection can have an important clinical effect on the clearance of mild to moderate eczema.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18306855

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  12 in total

1.  The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin.

Authors:  James Q Del Rosso; Jacqueline Levin
Journal:  J Clin Aesthet Dermatol       Date:  2011-09

2.  Moisturizers and Ceramide-containing Moisturizers May Offer Concomitant Therapy with Benefits.

Authors:  Chuck W Lynde; Anneke Andriessen; Benjamin Barankin; Gillian De Gannes; Wayne Gulliver; Richard Haber; Catherine McCuaig; Poonam Rajan; Sandra P Skotnicki; Richard Thomas; Jack Toole; Ron Vender
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

Review 3.  Multivesicular Emulsion Ceramide-containing Moisturizers: An Evaluation of Their Role in the Management of Common Skin Disorders.

Authors:  Joshua A Zeichner; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2016-12-01

4.  A Guide to the Ingredients and Potential Benefits of Over-the-Counter Cleansers and Moisturizers for Rosacea Patients.

Authors:  Jacquelyn Levin; Richard Miller
Journal:  J Clin Aesthet Dermatol       Date:  2011-08

5.  Topical corticosteroid application and the structural and functional integrity of the epidermal barrier.

Authors:  James Q Del Rosso; Kimberly Cash
Journal:  J Clin Aesthet Dermatol       Date:  2013-11

Review 6.  Emollients and moisturisers for eczema.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Robin Christensen; Adriana Lavrijsen; Bernd WM Arents
Journal:  Cochrane Database Syst Rev       Date:  2017-02-06

7.  Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroids.

Authors:  Hyun Jung Kim; Hyun Jung Park; Jae Nam Yun; Se Kyoo Jeong; Sung Ku Ahn; Seung Hun Lee
Journal:  Allergy Asthma Immunol Res       Date:  2011-02-14       Impact factor: 5.764

Review 8.  Oral evening primrose oil and borage oil for eczema.

Authors:  Joel T M Bamford; Sujoy Ray; Alfred Musekiwa; Christel van Gool; Rosemary Humphreys; Edzard Ernst
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

9.  Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients.

Authors:  Kam Lun Hon; Nga Hin Pong; Shuxin Susan Wang; Vivian W Lee; Nai Ming Luk; Ting Fan Leung
Journal:  Drugs R D       Date:  2013-03

10.  An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE Study Phase 1.

Authors:  Simon G Danby; Paul V Andrew; Kirsty Brown; John Chittock; Linda J Kay; Michael J Cork
Journal:  Dermatol Ther (Heidelb)       Date:  2020-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.